ES

Webinar: Biosimilars - What You Need to Know

Learn about biosimilars, equally effective biologics for inflammatory arthritis, and how they may impact your treatment plan. 

Webinar: Biosimilars

New Biologics for Inflammatory Arthritis

As patents for brand-name reference biologics expire, access to their biosimilars, equally effective biologic drugs for inflammatory arthritis, will expand. In this webinar, learn what this means for you and how it may affect your treatment plan.